Nasacort OTC Dual Allergy/Decongestion Relief Could Be Marketing Edge
This article was originally published in The Tan Sheet
Executive Summary
Sanofi’s Nasacort likely can carve out sales in the crowded nonprescription allergy market with promises of allergy relief plus decongestion in a product available OTC, unlike most competitors including Claritin D, Zyrtec D and Allegra D, which contain pseudoephedrine and are sold behind-the-counter.